We are live on ! Find out more
CC

Cannell Capital Portfolio holdings

AUM $163M
1-Year Est. Return 40.62%
This Fund
S&P 500
This Quarter Est. Return
-18.49%
1 Year Est. Return
+40.62%
3 Year Est. Return
+130.22%
5 Year Est. Return
+162.5%
10 Year Est. Return
+2,439.17%
AUM
$498M
AUM Growth
-$163M
Cap. Flow
-$22.3M
Cap. Flow %
-4.47%
Top 10 Hldgs %
51.11%
Holding
103
New
31
Increased
24
Reduced
20
Closed
13

Top Sells

Rank Stock Value
1
ODP
ODP
ODP
+$10.7M
2
EVER icon
EverQuote
EVER
+$8.47M
3
ARKO icon
ARKO Corp
ARKO
+$7.97M
4
PRDO icon
Perdoceo Education
PRDO
+$6.44M
5
PINS icon
Pinterest
PINS
+$5.81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.37%
2 Energy 17.34%
3 Communication Services 15.04%
4 Industrials 13.34%
5 Financials 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
76
Autolus Therapeutics
AUTL
$397M
$11K ﹤0.01%
+4,001
New +$12.2K
GBIO
77
DELISTED
Generation Bio
GBIO
$11K ﹤0.01%
+175
New +$11.4K
IVVD icon
78
Invivyd
IVVD
$158M
$11K ﹤0.01%
+3,357
New +$10.5K
SPRY icon
79
ARS Pharmaceuticals
SPRY
$509M
$11K ﹤0.01%
+2,569
New +$8.96K
TCRX icon
80
TScan Therapeutics
TCRX
$48.6M
$11K ﹤0.01%
+3,654
New +$10K
LENZ
81
LENZ Therapeutics
LENZ
$166M
$11K ﹤0.01%
+565
New +$12.6K
QTTB icon
82
Q32 Bio
QTTB
$466M
$11K ﹤0.01%
+320
New +$10.9K
FSTX
83
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$11K ﹤0.01%
+1,804
New +$6.08K
GANX icon
84
Gain Therapeutics
GANX
$71.7M
$10K ﹤0.01%
+2,751
New +$9.49K
IOBT
85
DELISTED
IO Biotech
IOBT
$10K ﹤0.01%
+2,192
New +$13.4K
OMGA
86
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$10K ﹤0.01%
+2,738
New +$10.2K
VIGL
87
DELISTED
Vigil Neuroscience
VIGL
$9K ﹤0.01%
+3,636
New +$14.4K
HCARW
88
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$8K ﹤0.01%
83,687
ELTX icon
89
Elicio Therapeutics
ELTX
$73.5M
$7K ﹤0.01%
+611
New +$9.76K
MOBXW icon
90
Mobix Labs Warrants
MOBXW
$6K ﹤0.01%
85,457
ARKO icon
91
ARKO Corp
ARKO
$896M
-875,519
Closed -$7.97M
CEE
92
Central and Eastern Europe Fund
CEE
$134M
-18,593
Closed -$249K
EVER icon
93
EverQuote
EVER
$892M
-523,735
Closed -$8.47M
GEG icon
94
Great Elm Group
GEG
$67.4M
-277,397
Closed -$502K
VIP
95
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$38.1M
-1,080
Closed -$93K
ONTF
96
DELISTED
ON24
ONTF
-335,000
Closed -$4.41M
PENN icon
97
PENN Entertainment
PENN
$2.75B
-11,250
Closed -$477K
PRDO icon
98
Perdoceo Education
PRDO
$1.99B
-560,859
Closed -$6.44M
NBIS
99
CALL
Nebius Group N.V.
NBIS
$48.3B
-1,830
Closed -$508K
EAR
100
DELISTED
Eargo, Inc. Common Stock
EAR
-51,427
Closed -$5.44M

Similar funds

Cannell Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Cannell Capital held 103 positions worth $498M, down 25% from $662M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cannell Capital withdrew a net $22.3M in Q2 2022, closing 13 positions and reducing 20 holdings. Its most notable exit was EverQuote, an estimated $8.47M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 27% a quarter earlier, followed by Energy and Communication Services.

Against the trend, Cannell Capital opened a new position in Tidewater worth $9.51M.

  • Cannell Capital's largest Q2 2022 buy was Tidewater: 450,780 shares worth $9.51M.
  • Cannell Capital added most to TrueCar in Q2 2022, an estimated $5.22M increase.
  • Cannell Capital's biggest Q2 2022 reduction was ODP, cutting an estimated $10.7M.
  • Cannell Capital fully exited EverQuote in Q2 2022, selling an estimated $8.47M.
  • Cannell Capital's ten largest holdings make up 51% of its $498M portfolio in Q2 2022.
  • Cannell Capital opened 31 new positions and closed 13 in Q2 2022.
  • Cannell Capital's portfolio value fell 25% quarter-over-quarter to $498M.

Based on Cannell Capital's 13F filing for Q2 2022, filed 15 Aug 2022.